Arrowpoint Investment Partners »

Syndax Pharmaceuticals shares owned by Arrowpoint Investment Partners

Quarter-by-quarter ownership of Syndax Pharmaceuticals (SNDX) shares owned by Arrowpoint Investment Partners from 13F filings

Historical chart of Arrowpoint Investment Partners investment in Syndax Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Syndax Pharmaceuticals held by Arrowpoint Investment Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Syndax Pharmaceuticals by Arrowpoint Investment Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $279k 13k 21.86

More positions owned by Arrowpoint Investment Partners

Vaneck Etf Trust Semiconductr Etf Call Option (SMH)
Citigroup Com New (C)
Goldman Sachs (GS)
State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Global Payments (GPN)
Norfolk Southern (NSC)
American Electric Power Company (AEP)
NVIDIA Corporation (NVDA)
Exxon Mobil Corporation (XOM)
Ishares Msci Sth Kor Etf Put Option (EWY)
Ishares Msci Taiwan Etf (EWT)
Alphabet Cap Stk Cl A (GOOGL)
Micron Technology (MU)
Ishares Tr Expanded Tech Call Option (IGV)
Intel Corporation (INTC)

View all positions for Arrowpoint Investment Partners

Top funds holding Syndax Pharmaceuticals

BlackRock
Kynam Capital Management
Goldman Sachs Group
State Street Corporation
Bank of America Corporation
Vanguard Capital Management
Deerfield Management Company
Eversept Partners
Geode Capital Management
Hood River Capital Management
Kingdon Capital Management
Franklin Resources
Millennium Management
Vanguard Portfolio Management
UBS Group

View all funds holding Syndax Pharmaceuticals